Amgen's total assets for Q1 2025 were $89.37B, a decrease of -2.69% from the previous quarter. GB:0R0T total liabilities were $83.16B for the fiscal quarter, a -3.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.